Concepedia

Quanlin An

QA

5

Publications

206

Citations

5

H-Index

2018

Active since

Affiliations

Shanghai University(Current)

Zhongshan Hospital

Huazhong University of Science and Technology

The First Affiliated Hospital, Sun Yat-sen University

University of Illinois Urbana-Champaign

Quanlin An is an author at Shanghai University specializing in gene expression, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2018–2022

5

Publications

5

Role of miR-221/222 in Tumor Development and the Underlying Mechanism

Qian Song, Quanlin An, Bing Niu et al. · Journal of Oncology · 2019 · 86 citations · Full text

, , +17

Inhibition of cancer stem cell like cells by a synthetic retinoid

Junwei Chen, Xin Cao, Quanlin An et al. · Nature Communications · 2018 · 75 citations · Full text

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway

Qi Feng, Wenxing Qin, Yao Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 20 citations · Full text

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches

Linfeng Zheng, Xiangyang Qin, Jiao Wang et al. · Biomolecules · 2022 · 13 citations · Full text

Synthetic Retinoid Kills Drug‐Resistant Cancer Stem Cells via Inducing RAR<i>γ</i>‐Translocation‐Mediated Tension Reduction and Chromatin Decondensation

Yao Zhang, Qi Dong, Quanlin An et al. · Advanced Science · 2022 · 12 citations · Full text

Rows per page

1–5 of 5